Shares of Heron Therapeutics (HRTX) are trading 23% higher at a price of $3.955 at the time of this writing.

Heron Therapeutics has been trading between a 52-week high of $12.89 and a 52-week low of $2.19. The stock has a market cap of $405 Million.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.

Earnings Scheduled For August 9, 2022
Benzinga 08-09-22

Earnings Outlook For Heron Therapeutics
Benzinga 08-08-22

Heron Therapeutics Q2 2022 Earnings Preview (NASDAQ:HRTX)
Seeking Alpha 08-08-22

Is Heron Therapeutics Inc. (NASDAQ: HRTX) Still A Buy After A 3.89% Weekly Jump?
Marketing Sentinel 08-05-22

Heron Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
PR Newswire 08-02-22


As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

SilverBirthday5 - 1 upvotes - source
HRTX. I got calls but i predict a miss lmao.